Search
Agencia Lei Va Hong
Zuellig
Kerry Pharma

AMGEN HONG KONG LIMITED

Featured products of Amgen
Amgevita
Amgevita soln for inj 40 mg/0.8 mL
adalimumab
Packing/Price
(pre-filled syringe/pen) 2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Blincyto
Blincyto powd for conc & soln for soln for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Evenity
Evenity soln for inj 105 mg/1.17 mL
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Kanjinti
Kanjinti powd & solvent for conc for soln for infusion 420 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kanjinti powd for conc for soln for infusion 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kyprolis
Kyprolis powd for soln for infusion 30 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Lumakras
Lumakras tab 120 mg
sotorasib
Packing/Price
2 × 120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
Mvasi
Mvasi conc for soln for infusion 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
Neulastim
Neulastim inj (pre-filled syringe) 6 mg/0.6 mL
pegfilgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen inj (vial) 0.3 mg/mL
filgrastim
Packing/Price
4 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen pre-filled inj 0.3 mg/0.5 mL
filgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1 mL x 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix conc for soln for infusion 20 mg/mL
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Distributed by Agencia Lei Va Hong
Blincyto
Blincyto powd for conc & soln for soln for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Evenity
Evenity soln for inj 105 mg/1.17 mL
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Kyprolis
Kyprolis powd for soln for infusion 30 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Neulastim
Neulastim inj (pre-filled syringe) 6 mg/0.6 mL
pegfilgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen inj (vial) 0.3 mg/mL
filgrastim
Packing/Price
4 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen pre-filled inj 0.3 mg/0.5 mL
filgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1 mL x 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix conc for soln for infusion 20 mg/mL
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Distributed by Zuellig
Amgevita
Amgevita soln for inj 40 mg/0.8 mL
adalimumab
Packing/Price
(pre-filled syringe/pen) 2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Blincyto
Blincyto powd for conc & soln for soln for infusion 35 mcg
blinatumomab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Evenity
Evenity soln for inj 105 mg/1.17 mL
romosozumab
Packing/Price
2 × 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Kanjinti
Kanjinti powd & solvent for conc for soln for infusion 420 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kanjinti powd for conc for soln for infusion 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Kyprolis
Kyprolis powd for soln for infusion 30 mg
carfilzomib
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.
Lumakras
Lumakras tab 120 mg
sotorasib
Packing/Price
2 × 120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.
Mvasi
Mvasi conc for soln for infusion 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
Neulastim
Neulastim inj (pre-filled syringe) 6 mg/0.6 mL
pegfilgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen inj (vial) 0.3 mg/mL
filgrastim
Packing/Price
4 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen pre-filled inj 0.3 mg/0.5 mL
filgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Parsabiv
Parsabiv soln for inj 2.5 mg/0.5 mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Parsabiv soln for inj 5 mg/mL
etelcalcetide hydrochloride
Packing/Price
10 × 1's
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1 mL x 1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
(autoinjector) 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix conc for soln for infusion 20 mg/mL
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Marketed by Kerry Pharma
Amgevita
Amgevita soln for inj 40 mg/0.8 mL
adalimumab
Packing/Price
(pre-filled syringe/pen) 2 × 1's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants
ATC Classification
L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.
Neulastim
Neulastim inj (pre-filled syringe) 6 mg/0.6 mL
pegfilgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen inj (vial) 0.3 mg/mL
filgrastim
Packing/Price
4 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen pre-filled inj 0.3 mg/0.5 mL
filgrastim
Packing/Price
1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in